{
    "nct_id": "NCT04046094",
    "official_title": "IV Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients: A Forgotten Group",
    "inclusion_criteria": "* Eastern Cooperative Oncology Group (ECOG) Performance Status = 0 -- 2\n* Cisplatin-ineligible, muscle invasive bladder cancer\n* Adequate organ and marrow functions\n* Women of child-bearing potential and men with partners of child-bearing potential must agree to use protocol specified forms of birth control\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patient simultaneously enrolled in any therapeutic clinical trial\n* Current or anticipated use of other investigational agents while participating in this study\n* Psychiatric illness/social situations that would limit compliance with study requirements\n* Pregnant or breast feeding. There is a potential for congenital abnormalities and for this regimen to harm breast feeding infants\n* Histology of pure adenocarcinoma, pure squamous cell carcinoma, or pure small cell carcinoma in the TURBT sample\n* Prior systemic chemotherapy (prior intravesical therapy is allowed) and/ or prior radiation therapy to the urinary bladder\n* Uncontrolled intercurrent illness\n* Current consumption of tobacco products\n* History of glucose-6-phosphate dehydrogenase (G6PD) deficiency",
    "miscellaneous_criteria": ""
}